logo-loader
viewNabis Holdings Inc.

Nabis Holdings completes stake in hot Israeli cannabis tech company Cannova Medical

The Vancouver cannabis investment company has the option to buy the remaining 51% in Cannova, which is pioneering sublingual CBD technology

A woman with a CBD sublingual strip
Cannova Medical uses sublingual strips that are infused with active cannabis substance

Nabis Holdings Inc (CSE:NAB), a cannabis investment company, said Tuesday that it has completed the acquisition of a 49% stake in Cannova Medical Ltd., which has a patented cannabis delivery technology platform.

The Vancouver cannabis investment company bought 2,260,500 shares representing a tidy 49% stake in Cannova Medical.

Nabis retains the option to acquire the remaining 51% of Cannova. If it decides to exercise that interest, Nabis must make a nominal cash payment and issue an additional 7.4 million shares to Cannova shareholders, held in escrow and subject to certain performance milestones.

Israel-based Cannova Medical’s line of cannabis sublingual strips overcome delivery and dosing challenges, providing easy-to-use, non-smoke solutions for consuming different types of cannabis or CBD formulations. Cannova’s controlled release oral thin films lead to dosing accuracy, enhanced efficacy, and safety in the delivery of cannabinoids.

“Our goal for strategic investments at Nabis is to enter multiple aspects of the cannabis sector including related technology,” said Nabis Holdings CEO Shay Shnet. “We are thrilled to have closed our 49% interest acquisition enabling the Cannova team to bring this disruptive technology to market at an increased pace.”

READ: Nabis Holdings makes strategic stake in Israeli cannabis consumables company

Cannova is also developing the NovaJet Pro, an innovative, counter-top machine that enables clients to create customized film strips in the convenience of their homes. With the NovaJet, clients will be able to receive accurate and tailored sublingual strips with specific measured quantities of cannabinoids and other natural substances.

According to the purchase agreement, Nabis will enjoy exclusive distribution rights to both Cannova’s sublingual strips, as well as the company’s NovaJet printing machine. The products will be marketed to both the recreational and medical markets.

“The combination of cannabis with smart and innovative technology is key to the future of both medical and recreational cannabis usage,” said Cannova Medical founder CEO Omri Schanin. “We are excited to work with the Nabis team leveraging their extensive experience and capabilities to help us reach our growth goals faster.”

In addition to the US and international cannabis sector, Nabis Holdings invests in assets across multiple industries, including real property, securities and cryptocurrency.

Contact Uttara Choudhury at [email protected]

Follow her on Twitter@UttaraProactive 

 

Quick facts: Nabis Holdings Inc.

Price: 0.07 CAD

CSE:NAB
Market: CSE
Market Cap: $7.65 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Nabis Holdings Inc. named herein, including the promotion by the Company of Nabis Holdings Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks reverse; Nabis Holdings jumps after securing...

The North American Marijuana Index, lost 1.5% to 136 points. The OTCQX Cannabis Index dipped 1.4% to 504 points. Buds today were Nabis Holdings Inc (CSE:NAB) (OTCMKTS:NABIF), EuroLife Brands Inc (CSE:EURO) (OTCMKTS:CANVF). Duds were HEXO Corp (TSE:HEXO)...

9 hours, 1 minute ago

2 min read